At 6%, Switzerland is at the European average for healthcare-associated infections (HAI). HAI refers to the infections that occur in connection with a diagnostic, therapeutic or nursing measure. If the infection occurs in a healthcare facility, such as a hospital, medical practice or nursing home, this is known as a nosocomial infection. In Switzerland, hospital-acquired infections result in around 70,000 cases of illness and 2,000 deaths each year. With disinfectants, consumables, diagnostics and IT systems, the medical technology industry already contributes greatly to preventing, detecting, monitoring and treating infections, and thus to preventing a lot of suffering and economic costs.
Who we are
The expert group Patient Safety comprises Swiss Medtech members, in particular manufacturers and dealers of consumables. It focuses on activities to improve patient protection against infections.
Who can participate
Employees of Swiss Medtech member companies, especially manufacturers and dealers of consumables, who wish to promote improvement of patient safety.
- Demonstrating the benefit of medical technology in preventing, diagnosing and fighting antibiotic resistance and nosocomial infections
- Considering international standards when assisting with and implementing binding guidelines on hospital hygiene and minimising resistance at federal and cantonal level
- Adequately mapping the prevention of infectious diseases in the SwissDRG reimbursement system and eliminating disincentives for reimbursement
- Developing holistic concepts with professional associations and partner organisations
- Supporting the federal government’s strategy to monitor, prevent and fight healthcare-associated infections (NOSO Strategy)
- Supporting the federal government’s Strategy on Antibiotic Resistance (StAR)
- Representing interests